Cronos Group Inc. (CRON) intrinsic value & 10-year financials

Cronos Group Inc. (CRON) has a Graham intrinsic value of CAD 3.65 per share. At CAD 3.21 on Oct 17, 2026, the stock trades 12% below that value. Over the last 10 fiscal years revenue grew 61.6% a year to CAD 146.6M, with an average return on invested capital of -28.9%.

Graham intrinsic value
CAD 3.65
Share price (Oct 17, 2026)
CAD 3.21
Price vs Graham value
12% below
Market cap
CAD 1.2B
Revenue (FY2025)
CAD 146.6M
Revenue growth (10-yr CAGR)
61.6%
ROIC (10-yr avg)
-28.9%
Free cash flow (FY2025)
CAD 149.0K

CRON 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 CAD 146.6M -CAD 9.4M -CAD 0.02 CAD 149.0K -11.9% -3.4%
FY2024 CAD 117.6M CAD 41.1M CAD 0.11 CAD 6.4M -65.1% -24.0%
FY2023 CAD 87.2M -CAD 74.0M -CAD 0.19 -CAD 45.3M -97.2% -20.0%
FY2022 CAD 91.9M -CAD 168.7M -CAD 0.45 -CAD 92.4M -135.8% -29.8%
FY2021 CAD 74.4M -CAD 396.1M -CAD 1.07 -CAD 164.8M -753.1% -101.9%
FY2020 CAD 46.7M -CAD 73.1M -CAD 0.21 -CAD 173.9M -383.9% -29.9%
FY2019 CAD 23.8M CAD 1.2B CAD 3.33 -CAD 168.7M -511.5% -21.8%
FY2018 CAD 12.1M -CAD 21.6M -CAD 0.07 -CAD 95.8M -176.1% -20.1%
FY2017 CAD 3.1M -CAD 1.5M -CAD 0.01 -CAD 37.2M -194.5% -9.0%
FY2016 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in CAD.

Executive summary

Cronos Group Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Cronos Group Inc. has historically struggled to out-earn its cost of capital, averaging just -33.0% ROIC.

Cronos Group Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Cronos Group Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $3.65 per share.

CRON stock: frequently asked questions

What is the intrinsic value of Cronos Group Inc. (CRON) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, CRON's intrinsic value is about CAD 3.65 per share.

Is CRON stock undervalued?

At CAD 3.21 (close on Oct 17, 2026), CRON trades 12% below its Graham value of CAD 3.65. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

Does Cronos Group Inc. generate free cash flow?

Cronos Group Inc. generated CAD 149.0K of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 2 of the last 9 reported years.

What is CRON's return on invested capital?

Average ROIC over the last 10 fiscal years was -28.9%, and average return on equity was 5.7%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this CRON data come from?

From Cronos Group Inc.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 6, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar medicinal chemicals & botanical products stocks